Illumina, Inc. - Common Stock (NQ:ILMN)

278.17 +13.60 (+5.14%)

Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

5 Must-Read Analyst Questions From Illumina’s Q2 Earnings Call

August 06, 2026

Illumina’s second quarter results reflected strong execution in its core clinical sequencing business, with management highlighting robust demand from U.S. a...

Via StockStory

Topics Earnings

Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗

August 05, 2026

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 3.84% on an annualized basis producing an average annual return of 13.26%. Currently, Illumina has a market capitalization...

Via Benzinga

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

August 04, 2026

Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results this Thursday after market close. Here’s what to expect. 10x Genomics beat anal...

Via StockStory

PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect

August 03, 2026

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday afternoon. Here’s what you need to know. PacBio mis...

Via StockStory

Illumina (NASDAQ:ILMN) Beats Q2 Estimates but Shares Slide 6% After-Hours ↗

July 30, 2026

Via Chartmill

Illumina (NASDAQ:ILMN) Scores Perfect Technical Rating and High Setup Quality for Breakout Trade ↗

July 30, 2026

Via Chartmill

Illumina (ILMN) Q2 2026 Earnings Call Transcript ↗

August 03, 2026

Clinical momentum and NovaSeq X placements drive revenue guidance raise.

Via The Motley Fool

Topics Earnings

3 Cash-Producing Stocks That Concern Us

August 03, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70? ↗

August 01, 2026

The developer of blood-based cancer tests still has a bright future.

Via The Motley Fool

Illumina Q2 Earnings Call Highlights ↗

July 31, 2026

Illumina (NASDAQ:ILMN) raised its 2026 revenue and earnings outlook after reporting second-quarter results that exceeded its expectations, supported by clinical sequencing demand, elevated NovaSeq X...

Via MarketBeat

Topics Earnings

ILMN Q2 Deep Dive: Clinical Strength, Platform Expansion, and Strategic Focus Drive Guidance Lift

July 31, 2026

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s...

Via StockStory

Illumina (ILMN) Q2 2026 Earnings Call Transcript ↗

July 30, 2026

Clinical momentum and NovaSeq X placements drive revenue guidance raise.

Via The Motley Fool

Topics Earnings

Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations

July 30, 2026

Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. ...

Via StockStory

Illumina Earnings: What To Look For From ILMN

July 28, 2026

Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday after market close. Here’s what to expect. Illumina beat analysts’ ...

Via StockStory

Topics Artificial Intelligence

3 Healthcare Stocks with Questionable Fundamentals

July 23, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron...

Via StockStory

3 Profitable Stocks We Find Risky

July 22, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong. ↗

July 13, 2026

The fate of Grail's stock will ultimately be decided in the cost-benefit calculations of medical insurers.

Via The Motley Fool

2 Mooning Stocks Worth Investigating and 1 We Avoid

July 09, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)

July 06, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Topics Artificial Intelligence Economy

1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky

July 06, 2026

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo...

Via StockStory

Topics Energy

Prediction: Grail Stock Will Skyrocket to $100 in 1 Year ↗

July 02, 2026

The cancer test maker still has a bright future.

Via The Motley Fool

3 Mid-Cap Stocks That Concern Us

July 02, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

Via StockStory

Why Illumina (ILMN) Stock Is Down Today

June 30, 2026

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation ge...

Via StockStory

Why Illumina (ILMN) Stock Is Trading Up Today

June 24, 2026

What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to ...

Via StockStory

June 16, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

Topics Artificial Intelligence

Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗

June 08, 2026

Grail is on a quest to win in a $50 billion market.

Via The Motley Fool

Is Grail Stock a Bad-News Buy After Its Recent Pullback? ↗

June 04, 2026

The cancer test maker could still have a bright future.

Via The Motley Fool

1 Cash-Producing Stock Worth Investigating and 2 We Question

June 01, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

3 Healthcare Stocks That Fall Short

May 28, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking...

Via StockStory

This Beaten-Down Growth Stock Could Soar 30%, According to Wall Street ↗

May 18, 2026

Grail's Galleri trial was disappointing, but it isn't down for the count yet.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.